Lotus Biotech Development Corp. - FORM 10-Q/A - February 25, 2013

Attached files

file filename
EX-32.1 - SARBANES-OXLEY 906 CERTIFICATION. - Lotus Biotech Development Corp.exh32-1.htm
EX-31.1 - SARBANES-OXLEY 302 CERTIFICATION. - Lotus Biotech Development Corp.exh31-1.htm




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q/A-1

[X]
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012
 
OR
 
[   ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number   000-54745
 
STARFLICK.COM
(Exact name of registrant as specified in its charter)
 
Nevada
(State of incorporation)

1361 Peltier Drive
Point Roberts, Washington 98281
(Address of principal executive offices)
 
(403) 708-2523
(Registrant’s telephone number)

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.   YES [X]     NO [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (SS 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   YES [   ]     NO [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer, “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 
Large Accelerated Filer
[   ]
  
Accelerated Filer
[   ]
 
Non-accelerated Filer
[   ]
  
Smaller Reporting Company
[X]
 
(Do not check if smaller reporting company)
      

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   YES [X]     NO [   ]

APPLICABLE ONLY TO CORPORATE ISSUERS:

As of July 25, 2012, there were 5,384,500 shares of the registrant’s $0.00001 par value common stock issued and outstanding.

 

 


REASON FOR AMENDMENT

The company is required by FINRA to change the company status to Shell Company and required the Company to tick the shell box, no other changes were required to be amended or changed.











 
Page
 
  
 
  
  
EXHIBITS.
3
 
    
4
 
  
5











-2-
 

 
PART II - OTHER INFORMATION

ITEM 6.                 EXHIBITS.

   
Incorporated by reference
  
Exhibit
Document Description
Form
Date
Number
Filed
herewith
 
          
3.1
Articles of Incorporation.
S-1
6/10/11
3.1
  
 
          
3.2
Bylaws.
S-1
6/10/11
3.2
  
 
          
14.1
Code of Ethics.
10-K
6/22/12
14.1
  
 
          
31.1
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
      
X
 
          
32.1
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
      
X
 
          
99.2
Audit Committee Charter.
10-K
6/22/12
99.2
  
 
          
99.3
Disclosure Committee Charter.
10-K
6/22/12
99.3
  
 
          
101.INS
XBRL Instance Document.
      
 
 
          
101.SCH
XBRL Taxonomy Extension – Schema.
      
 
 
          
101.CAL
XBRL Taxonomy Extension – Calculations.
      
 
 
          
101.DEF
XBRL Taxonomy Extension – Definitions.
      
 
 
          
101.LAB
XBRL Taxonomy Extension – Labels.
      
 
 
          
101.PRE
XBRL Taxonomy Extension – Presentation.
      
 



 
-3-


SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this amended report to be signed on its behalf by the undersigned thereunto duly authorized on this 25th day of February, 2013.

 
STARFLICK.COM
   
 
BY:
ZOLTAN NAGY
   
Zoltan Nagy
   
President, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, Secretary, Treasurer and sole member of the Board of Directors


























 
-4-


EXHIBIT INDEX

   
Incorporated by reference
  
Exhibit
Document Description
Form
Date
Number
Filed
herewith
 
          
3.1
Articles of Incorporation.
S-1
6/10/11
3.1
  
 
          
3.2
Bylaws.
S-1
6/10/11
3.2
  
 
          
14.1
Code of Ethics.
10-K
6/22/12
14.1
  
 
          
31.1
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
      
X
 
          
32.1
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
      
X
 
          
99.2
Audit Committee Charter.
10-K
6/22/12
99.2
  
 
          
99.3
Disclosure Committee Charter.
10-K
6/22/12
99.3
  
 
          
101.INS
XBRL Instance Document.
      
 
 
          
101.SCH
XBRL Taxonomy Extension – Schema.
      
 
 
          
101.CAL
XBRL Taxonomy Extension – Calculations.
      
 
 
          
101.DEF
XBRL Taxonomy Extension – Definitions.
      
 
 
          
101.LAB
XBRL Taxonomy Extension – Labels.
      
 
 
          
101.PRE
XBRL Taxonomy Extension – Presentation.
      
 








 
-5-
 

Lotus Biotech Development Corp. Reports